Genpharmasec

Genpharmasec AAQS

The The AAQS of Genpharmasec (531592.BO) as of Oct 30, 2026 is 5. In the previous year, The AAQS was 5.00 — a change of 0.00% (lower).

AAQS

5

YoY

0.00%

Last updated:

Genpharmasec has a current AAQS of 5.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Genpharmasec in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Genpharmasec AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
5.00 INR
Jan 1, 2019
5.00 INR
Jan 1, 2020
5.00 INR
Jan 1, 2021
5.00 INR
Jan 1, 2022
5.00 INR
Jan 1, 2023
5.00 INR
Jan 1, 2024
5.00 INR
Jan 1, 2025
5.00 INR
The Genpharmasec AAQS history
YEARAAQSYoY
50.00%
50.00%
50.00%
50.00%
50.00%
50.00%
50.00%
50.00%
50.00%
50.00%
50.00%
5—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genpharmasec Stock analysis

What does Genpharmasec do? Genpharmasec Ltd. generates revenue through the manufacturing and trading of organic and inorganic chemicals, dyes, and pigments, with key products including potassium hydroxide and caustic soda. The company operates in two main segments: the distribution of diagnostic equipment and investment and trading in securities. Its primary customers are businesses requiring chemical products for industrial applications, while the diagnostic equipment segment serves healthcare providers needing medical devices. The securities trading segment targets institutional investors seeking financial market participation. The company's chemical products are sold to industrial clients across various sectors, leveraging its manufacturing capabilities for potassium hydroxide and caustic soda. Diagnostic equipment distribution caters to healthcare institutions requiring specialized medical tools, while securities trading involves active market participation for financial gains. These segments collectively drive the company's revenue streams without relying on external partnerships or third-party services. Revenue is derived from direct sales of chemical products, distribution of diagnostic equipment, and trading activities in securities. The firm's operational focus remains on chemical manufacturing and trading, diagnostic equipment distribution, and securities investment, with no mention of additional revenue sources or external dependencies in its business description. Genpharmasec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genpharmasec stock

The AAQS of Genpharmasec is 5 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Genpharmasec since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Genpharmasec

All Key Metrics — Genpharmasec